FDA Turns Over Dendreon Documents - Here They Are [View article]
Dr. Scher and Dr. Hussain are not independent. Simply "follow the money" and anyone will quickly discover these two FDA Advisory Committee members have ties to those with interests that are in direct conflict with the Provenge approval.
Seems to me the bigger story is not the results of Provenge, but the approval process, obvious conflicts of interests involved, and the huge implications that flow from this.....
Surely, a committee member that is found to have a personal conflict of interest, and is vested in the results of an approval/disapproval of any drug, should not be allowed to sit on this this advisory panel and advocate either way. Yes?
With a small amount time and effort, an ambitious investigative reporter could easily pull all the pieces together and have a "career making" story to tell. I'm sure it would be a wild ride, from hedge funds with massive short interests, to multinational drug companies, to back room deal making with those who could influence the outcome. It would be an engaging and eye opening expose'.
Mike Huckman, are you still there? Hello? Hmmm.... maybe 60 minutes or 20/20 will take the initiative breathe some life into this saga and shed the light of truth on this travesty.
-
Dr. Scher and Dr. Hussain are not independent. Simply "follow the money" and anyone will quickly discover these two FDA Advisory Committee members have ties to those with interests that are in direct conflict with the Provenge approval.
Mar 06 12:47 pm
|Rating:
0
0
All Comments by User 8136 »FDA Turns Over Dendreon Documents - Here They Are [View article]
Seems to me the bigger story is not the results of Provenge, but the approval process, obvious conflicts of interests involved, and the huge implications that flow from this.....
Surely, a committee member that is found to have a personal conflict of interest, and is vested in the results of an approval/disapproval of any drug, should not be allowed to sit on this this advisory panel and advocate either way. Yes?
With a small amount time and effort, an ambitious investigative reporter could easily pull all the pieces together and have a "career making" story to tell. I'm sure it would be a wild ride, from hedge funds with massive short interests, to multinational drug companies, to back room deal making with those who could influence the outcome. It would be an engaging and eye opening expose'.
Mike Huckman, are you still there? Hello? Hmmm.... maybe 60 minutes or 20/20 will take the initiative breathe some life into this saga and shed the light of truth on this travesty.